Cryo-Cell International (CCEL) vs DocGo (DCGO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cryo-Cell International (CCEL) has outperformed DocGo (DCGO) over the past year, losing 6.9% versus a loss of 73.1%. Over five years, CCEL leads with a -68.3% price change compared with -96.6% for DCGO. DocGo is the larger company by market cap ($34.9 million vs $32.3 million), about 1.1 times the size.
On valuation, DocGo trades at a lower forward P/E (9.1x vs 200.0x for Cryo-Cell International).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCEL | DCGO |
|---|---|---|
| Share price | $4.00 | $0.353 |
| Market cap | $32.25M | $34.94M |
| 1-day change | -4.08% | +4.22% |
| YTD return | +21.22% | -61.42% |
| 1-year return | -6.92% | -73.12% |
| 5-year return | -68.29% | -96.61% |
| Forward P/E | 200.00 | 9.10 |
| EPS (TTM) | $-0.31 | $-1.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.90 | $1.65 |
| 52-week low | $2.72 | $0.311 |
| Distance from 52-week high | -18.37% | -78.61% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +432.58% |
| Average volume | 24.02K | 722.71K |
| Shares outstanding | 8.06M | 98.99M |
| Employees | 72 | 2,537 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CCEL has outperformed DCGO by 66.2 percentage points over the past year.
About Cryo-Cell International
CCEL stock →Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
Health Care · Misc Health and Biotechnology Services · 72 employees
About DocGo
DCGO stock →DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom.
Health Care · Medical/Nursing Services · 2,537 employees
CCEL vs DCGO FAQ
Which is bigger, Cryo-Cell International or DocGo?
DocGo (DCGO) is larger, with a market capitalization of $34.94M compared with $32.25M for Cryo-Cell International (CCEL).
Which stock has performed better over the past year, CCEL or DCGO?
CCEL returned -6.92% over the past 12 months, compared with -73.12% for DCGO (price return, excluding dividends). Past performance does not predict future results.
Are Cryo-Cell International and DocGo in the same industry?
Both are in the Health Care sector, but in different industries: Misc Health and Biotechnology Services for Cryo-Cell International and Medical/Nursing Services for DocGo.